Titre:
  • Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.
Auteur:Dieci, Maria Vittoria; Radosevic-Robin, Nina; Fineberg, Susan; Van den Eynden, Gert; Ternes, Nils; Pénault-Llorca, Frederique; Pruneri, Giancarlo; D'Alfonso, Timothy TM; Demaria, Sandra; Castaneda, Carlos; Sanchez, Joselyn; Badve, Sunil; Michiels, Stefan; Bossuyt, Veerle Ilse Julie; Rojo, Federico; Singh, Baljit; Nielsen, Torsten; Viale, Giuseppe; Kim, Seong-Rim; Hewitt, Stephen M; Wienert, Stephan; Loibl, Sibylle; Rimm, David D.L.; Symmans, Fraser; Denkert, Carsten; Adams, Sylvia; Loi, Sherene; Salgado, Roberto; International Immuno-Oncology Biomarker Working Group on Breast Cancer,
Informations sur la publication:Seminars in cancer biology, 52, Pt 2, page (16-25)
Statut de publication:Publié, 2018
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Breast cancer
Ductal carcinoma in situ
Neoadjuvant
Residual cancer burden
Residual disease
Tumor-infiltrating lymphocytes
MeSH keywords:Biomarkers, Tumor -- immunology
Breast Neoplasms -- immunology
Carcinoma in Situ -- immunology
Female
Humans
Lymphocytes, Tumor-Infiltrating -- immunology
Medical Oncology -- methods
Neoadjuvant Therapy -- methods
Neoplasm, Residual -- immunology
Langue:Anglais
Identificateurs:urn:issn:1044-579X
info:doi/10.1016/j.semcancer.2017.10.003
info:pii/S1044-579X(17)30217-1
info:pmid/29024776